Joel Kaufman

Joel Kaufman has a diverse and extensive work experience. Joel is currently the Chief Financial Officer at Haystack Oncology starting from December 2022. Before that, they served as the Vice President of Finance & Corporate Development at Sema4 from May 2021 to December 2022. Prior to that, they worked at Navidea Biopharmaceuticals as the Chief Business Officer from November 2020 to May 2021, and as the Head of Corporate Strategy and Business Development from October 2017 to May 2021. Joel also held the position of Head of Strategy and Business Development at Macrophage Therapeutics from October 2017 to May 2021. Joel began their career at Goldman Sachs as an Intern in June 2010 and later worked as an Analyst in the Life Sciences & Diagnostics sector from July 2011 to June 2014, and as an Equity Research Associate in the Medical Technology sector from June 2014 to October 2017.

Joel Kaufman attended Atlantic City High School from 2003 to 2007, where they obtained their high school education. Joel then pursued a Bachelor of Arts (BA) degree in Neuroscience, Economics, and Healthcare Management from the University of Pennsylvania from 2007 to 2011. More recently, from 2019 to 2021, Joel attended Northwestern University - Kellogg School of Management, where they earned a Master of Business Administration (MBA) degree. The field of study for their MBA is not specified.